Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
*Substitute soup $2.50
Since GLP-1 patches arent FDA approved, theres no guarantee of quality or consistency, and they havent been tested in clinical trials, so theres no long-term safety data
A 2026 study published in The Lancet suggests that tirzepatide, a dual GLP-1 and GIP receptor agonist already approved for treatment of diabetes and obesity, could be an effective tool for fighting alcohol use disorder (AUD)
Sometimes, drug shortages, changes to your insurance coverage or your financial situation, and other circumstances beyond your control can force you to stop taking medication abruptly or take less than youre used to
US$ 27.75
US$ 29.42
US$ 29.72
US$ 25.66
US$ 25.07
